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Objective: To compare measurement properties of the P4 pain scale, Western Ontario and McMaster
Universities Arthritis Index pain subscale (WOMAC-pain), and Intermittent and Constant Osteoarthritis
Pain (ICOAP) measure in patients with knee osteoarthritis (OA).
Design: A secondary analysis from a randomized controlled trial included participants (n ¼ 156) with
knee OA that were consulting with a surgeon regarding knee arthroplasty. They completed pain mea-
sures (P4, WOMAC-pain, ICOAP) and WOMAC-function subscale (WOMAC-function) at baseline and 2
weeks. Measurement properties assessed in various subgroups included ﬂoor/ceiling effects, test-retest
reliability using intraclass correlation coefﬁcients (ICC2,1), internal consistency using Cronbach’s ɑ,
factorial structure of each pain measure combined with WOMAC-function using principal component
analysis, and responsiveness using standardized response mean (SRM).
Results: P4 had low ﬂoor and ceiling effects (<1%). P4 test-retest reliability (ICC2,1 ¼ 0.72), internal
consistency (Chronbach’s ɑ ¼ 0.91), and responsiveness (SRM ¼ 0.56) were similar to the values for
WOMAC-pain and ICOAP. Factorial structure of P4 and ICOAP were separate from WOMAC-function
items. WOMAC-pain and WOMAC-function items loaded on similar factors. ICOAP-constant subscale
had a large ﬂoor effect (33%).
Conclusions: P4 should be used to measure pain in patients with knee OA. It had acceptable measure-
ment properties which is comparable to more widely used pain measures. WOMAC-pain shared a
factorial structure with WOMAC-function indicating these measures might be capturing the same
construct, questioning its validity to measure pain separately from function. ICOAP had acceptable
properties. More work should compare pain measures in less severely affected OA populations.
 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Patients with knee osteoarthritis (OA) report signiﬁcantly
higher pain intensity compared to healthy adults1. Guidelines
suggest that pain should be measured to determine treatment
response in clinical knee OA trials and outcome measures withto: S.M. Robbins, School of
Gill University, 3654 Prome-
, Canada. Tel: 1-514-398-
obbins), ravi.rastogi@lhsc.on.
), richard.rosedale@lhsc.on.ca
ternational. Published by Elsevier Lacceptable measurement properties are required to assess this
response2,3. Numerous pain measures exist and a comparison of
measurement properties is needed to determine the most appro-
priate one for this population4e7.
Perhaps the most frequently used disease speciﬁc pain measure
in knee OA is the pain subscale of the Western Ontario and
McMaster Universities Arthritis Index (WOMAC-pain)4. For
instance, WOMAC-pain was used in 45% of randomized controlled
trials evaluating physical therapy interventions for knee OA8. A
review found that WOMAC-pain has demonstrated acceptable test-
retest reliability, high internal consistency, small to large effect
sizes (responsiveness) depending on the intervention, and
convergent construct validity with other pain measures9. Despite
these ﬁndings, criticisms of the WOMAC exist. The ﬁve WOMAC-td. All rights reserved.
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activities (e.g., “walking on a ﬂat surface”) and thus WOMAC-pain
might not be able to differentiate between changes in pain and
physical function10. As evidence, high correlations between
WOMAC-pain and WOMAC-physical function (WOMAC-function)
subscales (r > 0.84) exist11. Also, factorial analysis demonstrated
that WOMAC-pain items (e.g., “going up or down stairs”) load on
the same factors as the correspondingWOMAC-function items (e.g.,
“descending stairs”) demonstrating they are measuring the same
construct7,10e12. Thus, WOMAC-pain might be capturing both
physical function status and pain status.
If evaluating pain is of primary interest then the outcome
measure should solely examine this construct. In response to the
WOMAC-pain limitations, other pain measures have been recom-
mended for knee OA. The P4 pain scale was developed for use in
the patients with musculoskeletal conditions making it a generic
pain measure13,14. It has high internal consistency (Chronbach’s
ɑ ¼ 0.93) in patients with knee OA7. P4 also demonstrated
discriminant validity and its factorial structure was separate from
WOMAC-function in patients with knee OA7. Another disease
speciﬁc pain measure, the Intermittent and Constant Osteoar-
thritis Pain (ICOAP) measure, was recently developed6. It has the
advantage of examining intermittent and constant pain domains
separately. It has shown good test-retest reliability (intraclass
correlation coefﬁcient ¼ 0.85), high internal consistency (Chron-
bach’s ɑ ¼ 0.93), and responsiveness (standardized response mean
(SRM)  0.56) in patients with hip or knee OA6,15e17. Both P4 and
ICOAP are alternatives to WOMAC-pain and they might provide
a more accurate representation of pain status in patients with
knee OA.
P4 has great clinical utility because it is a generic pain scale that
can be used with a variety of musculoskeletal conditions, is quickly
completed, and easy to score. However, only one study to date has
examined its measurement properties in a knee OA sample7. If the
P4 is to be used as an outcome measure to capture pain in patients
with knee OA, further testing of its measurement properties and
comparisons to other pain measures are needed. The purpose was
to determine the measurement properties (reliability, responsive-
ness, factorial structure) of the P4, a generic pain scale, in patients
with knee OA and compare these properties to disease speciﬁc pain
scales including WOMAC-pain and ICOAP. It was hypothesized that
the P4 would have similar measurement properties as WOMAC-
pain and ICOAP including good test-retest reliability, acceptable
internal consistency, and moderate responsiveness. Additionally,
the factorial structure of P4 would be separate from a physical
function measure.Method
Participants
The current study is a secondary analysis from a randomized
controlled trial examining the efﬁcacy of exercise intervention as
determined by the McKenzie System of Mechanical Diagnosis and
Therapy in participants with knee OA (clinicaltrials.gov registration
numberNCT01641874)18. Participants had a radiologically conﬁrmed
diagnosis of knee OA made by an orthopedic surgeon and had pain
for at least 4 months. Participants were recruited during a visit to an
orthopedic surgeon at a tertiary healthcare center between
November 2009 and April 2012. Participants were being assessed for
a potential knee arthroplasty with some participants eventually
being scheduled for surgery. Exclusion criteria included current or
previous neurological conditions (e.g., history of stroke) or unable to
understand written or spoken English.Participants were randomly assigned to an intervention or
control group in a 2:1 ratio since the intervention groupwas further
divided into subgroups for the primary study18. The control group
received the standard of care which included pain medication and
continued follow-upwith an orthopedic surgeon. Theywere able to
continue with any pain medication they were taking upon study
enrollment, did not receive additional treatment, and did not
receive placebo treatment. The intervention group also continued
with their pain medications. Participants in the intervention group
were classiﬁed according to the Mechanical Diagnosis and Therapy
guidelines and received either directional preference exercises or
an evidence based knee OA exercise program18. Directional pref-
erence exercises included repeated, end-range movements, either
knee ﬂexion or extension, that were shown to improve the patient’s
symptoms during functional activities18. The evidence based exer-
cise program included range of motion exercises, strengthening,
and advice on aerobic exercise (e.g., walking or biking)18.
Data for the current analyses included baseline and 2 week
measurements. The procedures followed were in accordance with
the ethical standards of the responsible committee on human
experimentation and with the Helsinki Declaration. The study
protocol was approved by the Western University Health Sciences
Research Ethics Board in London, Canada. Written, informed con-
sent was obtained from all participants prior to study enrollment.
Pain measures
P4 pain scale
P4 measures pain intensity and includes four items on an 11-
point numeric scale (0 ¼ no pain, 10 ¼ pain as bad as it can
be)13,14. Participants are required to rate their pain in the morning,
afternoon, evening, and with activity (e.g., “On average, how bad
has you pain been in the morning over the past 2 days?”)13,14. The
four items are summed and the maximum score is 40 representing
intense pain.
Western Ontario and McMaster Universities Arthritis Index
Participants completed the Knee Injury and Osteoarthritis
Outcome Score and the Likert 3.1 version of the WOMAC was
extracted4,19. Only the WOMAC-pain and physical function sub-
scales were considered for this study. These subscales include ﬁve
and 17 items respectively with each item on a 5 point scale. The
WOMAC-pain requires participants to rate their pain intensity
(0 ¼ none, 4 ¼ extreme) during functional activities (e.g., “walking
on a ﬂat surface”). The WOMAC-function requires participants to
rate their degree of difﬁculty (0 ¼ none, 4 ¼ extreme) performing
functional activities (e.g., “ascending stairs”). The items are sum-
med for each subscale. The WOMAC-pain and WOMAC-function
subscales have maximum scores of 20 and 68 respectively with
higher scores representing increased pain and increased difﬁculty
performing functional activities.
ICOAP measure
The ICOAP is an 11 item measure with two subscales measuring
constant pain (ICOAP-constant; ﬁve items) and intermittent pain
(ICOAP-intermittent; six items)6. The majority of items require
participants to rate intensity of symptoms, how pain affects activ-
ities (e.g., sleep), and how pain affects emotions using a 5 point
scale (0 ¼ not at all, 4 ¼ extremely). One item from ICOAP-
intermittent measures frequency of pain (0 ¼ never, 4 ¼ very
often). ICOAP subscales (ICOAP-constant, ICOAP-intermittent) and
total score (ICOAP-total) are created by summing appropriate items
and then converting to a 0e100 scale with higher scores repre-
senting extreme pain.
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Age, height, andweight were collected from participants by self-
report or from medical charts. Participants also underwent
anterior-posterior radiographs as part of their usual standard of
care and disease severity was scored by an orthopedic surgeon
(J.H.) using the KellgreneLawrence severity scores20. Participants
were randomized to control or intervention groups and completed
baseline pain measures. Participants received their respective
treatment and then pain measures were collected again at 2 weeks.
Statistical analysis
Descriptive statistics for sample characteristics and pain mea-
sures were calculated for the entire sample, as well as for the
control and intervention groups separately at both baseline and 2
weeks. Statistical analyses were performed using SPSS Version 20
(IBM, Chicago, IL) and Matlab version 7.14 (MathWorks, Natick,
MA).
Floor and ceiling effects
Baseline data from the entire sample was used to examine ﬂoor
and ceiling effects by calculating percentages of participants with
the minimum and maximum possible scores respectively. A limit of
15% of participants was used to determine which measures had
unacceptable ﬂoor or ceiling effects21.
Test-retest reliability
Test-retest reliability examines the stability of a measure22.
Control group baseline and 2 week data were used to examine test-
retest reliability for each pain measure. It was assumed their pain
levels would remain stable over this time period since they were
not receiving additional interventions including placebos. Test-
retest reliability was evaluated using intraclass correlation co-
efﬁcients model 2,1 (ICC2,1) with 95% conﬁdence intervals (CI)23.
This statistic examines how well a measure distinguishes among
participants. ICC2,1 values greater than 0.75 were considered good
test-retest reliability and values below 0.75 considered poor to
moderate22. ICC2,1 assumptions were examined including
normality and equal variances. Reliability was also examined using
standard error of measurement (SEM) with 95% CI and minimal
detectable change at the 90% conﬁdence level (MDC90)22,24. SEM
and MDC90 were calculated using the mean square error terms
from the analyses of variance (ANOVA) used in the ICC2,1 calcula-
tions22,24. SEM provides an estimate of measurement error in the
same units as the original outcome24. MDC90 represents the
amount of change in a measure that must occur in order to be
considered a true change at 90% conﬁdence22.
Internal consistency
Internal consistency is the extent which items from a measure
are capturing the same construct22. It was estimated using Chron-
bach’s ɑ from the entire sample’s baseline data22. Values above 0.80
were considered acceptable internal consistency25.
Factorial structure
Factorial structure of the pain measures were examined using
principal components analysis with direct oblimin rotation using
baseline data from the entire sample26. This analysis was explor-
atory, as opposed to conﬁrmatory factor analysis, since previous
analyses of WOMAC-pain, WOMAC-function, and ICOAP have failed
to conﬁrm their intended factorial structure6,7,27. This analysis
identiﬁes different factors from outcomemeasure items and groups
these items based on how they relate to these factors. The factors
can often represent a particular construct (e.g., pain or physicalfunction). Factors with eigenvalues greater than one were retained.
Similar to the methods performed by Stratford and colleagues7, the
four items from P4 were combined with WOMAC-function items.
The principal component analysis was expected to yield two or
three factors with P4 items loading on one factor and WOMAC-
function items loading on remaining factors. This would indicate
that P4 items are measuring a separate construct than WOMAC-
function items. This analysis was repeated for WOMAC-pain/
WOMAC-function and ICOAP/WOMAC-function. For ICOAP/
WOMAC-function analysis, it was expected ICOAP items would
load on two factors representing constant and intermittent sub-
scales and WOMAC-function would load on remaining factors.
Assumptions for these analyses were examined including the
Kaiser-Meyer-Olkin Measure to examine sampling adequacy and
Bartlett’s Test to ensure inter-item correlations were acceptable.
Responsiveness
Responsiveness is the ability of a measure to detect change and
it was estimated using the SRM22,28. SRM is the mean change from
pre-intervention to post-intervention divided by standard devia-
tion of these change scores. SRM values of 0.20, 0.50, and 0.80
represent small, moderate, and large responsiveness respectively28.
Intervention group baseline and 2 weeks scores were used to
calculate SRM since it was expected that this group would have
reduced pain post-treatment. To calculate 95% CI around SRM es-
timates, a bootstrap procedure with 1000 samples was
completed10. SRM for each pain measure was determined for each
of the 1000 samples and the lowest twenty-ﬁfth observation and
highest twenty-ﬁfth observation represented 95% CI.
Results
The entire sample consisted of 156 participants randomly
assigned to control (n ¼ 57) and intervention (n ¼ 99) groups.
Descriptive statistics for participant characteristics and baseline
pain measures are provided in Table I. The majority of participants
in the entire sample (57%) had severe knee OA (grade 4) according
to the KellgreneLawrence disease severity scores (Table I). Within 9
months after the last participant was enrolled, 51% of participants
had surgery including total knee arthroplasty (n ¼ 76), uni-
compartment knee arthroplasty (n ¼ 1), and high tibial osteot-
omy (n ¼ 3). There was some missing baseline data including one
participant for WOMAC-pain, one participant for ICOAP, and two
participants for WOMAC-function.
Floor and ceiling effects
For P4 and WOMAC-pain, the percentage of participants from
the entire sample (n ¼ 156) with either the minimum (ﬂoor effect)
or maximum (ceiling effect) score at baseline was less than 1% for
bothmeasures and both effects. The ﬂoor effect for ICOAP-constant,
ICOAP-intermittent, and ICOAP-total was 33%, 6% and 1% respec-
tively. The ceiling effect was 2%, 3%, and 2% for ICOAP-constant,
ICOAP-intermittent, and ICOAP-total respectively. Thus, only
ICOAP-constant demonstrated a ﬂoor effect greater than the 15%
limit.
Test-retest reliability
Four participants from the control group did not complete 2
week testing and were not included in test-retest reliability anal-
ysis (n ¼ 53). Descriptive statistics for baseline and 2 week scores
used in test-retest reliability analyses are provided in Table II.
WOMAC-pain and ICOAP-constant had good reliability with
ICC2,1 > 0.75 while P4 and ICOAP-total had values just below this
Table I
Descriptive statistics for participant characteristics and baseline outcomes
Variable Entire sample (n ¼ 156)
Mean (SD)
MineMax
Control (n ¼ 57)
Mean (SD)
MineMax
Intervention (n ¼ 99)
Mean (SD)
MineMax
Age (y) 65 (10)
41e85
64 (11)
41e85
66 (10)
46e85
Mass (kg)* 88.2 (20.2)
37.6e173.4
85.6 (16.3)
54.5e127.0
89.6 (22.1)
37.6e173.4
Height (m)* 1.68 (0.10)
1.40e1.96
1.67 (0.10)
1.49e1.88
1.69 (0.10)
1.40e1.96
BMI (kg/m2)* 31.2 (6.9)
16.8e57.0
30.7 (5.3)
21.0e41.5
31.4 (7.7)
16.8e57.0
Sex frequency (%)y Men 67 (43%) 23 (40%) 44 (44%)
Women 89 (57%) 34 (60%) 55 (56%)
P4 pain scale 21 (9)
0e40
23 (8)
7e40
21 (10)
0e38
WOMAC-pain 9 (4)
0e20
10 (4)
3e20
9 (4)
0e17
ICOAP-total 45 (24)
0e100
48 (25)
11e100
43 (23)
0e100
ICOAP-constant 35 (32)
0e100
40 (34)
0e100
33 (31)
0e100
ICOAP-intermittent 53 (25)
0e100
55 (27)
0e100
51 (24)
0e100
WOMAC-function 31 (12)
4e68
33 (12)
11e68
30 (12)
4e61
KellgreneLawrence severity
score frequency (%)*,y <2
0 (0%) 0 (0%) 0 (0%)
2
20 (13%) 10 (18%) 10 (10%)
3
46 (30%) 17 (31%) 29 (29%)
4
88 (57%) 28 (51%) 60 (61%)
BMI, body mass index; WOMAC, Western Ontario and McMaster Universities Arthritis Index; ICOAP, Intermittent and Constant Osteoarthritis Pain measure; SD, standard
deviation; Min, minimum score; Max, maximum score.
* Mass, height, and BMI data were not available for 15 participants and KellgreneLawrence severity score for two participants.
y Frequency (percentages) is provided for sex and KellgreneLawrence severity scores.
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SEM and MDC90 values are also provided in Table II.
The normality assumption for the ICC2,1 was however violated
for ICOAP-constant and ICOAP-total due to the high ﬂoor effect of
ICOAP-constant. Transformations did not substantially and consis-
tently improve normality. Thus, participants in the control group
with an ICOAP-constant score of 0 at baseline were removed which
resulted in normal data. ICC2,1 values for the remaining control
participants (n ¼ 37) for ICOAP-constant was 0.78 (95% CI 0.61e
0.88) and ICOAP-total was 0.68 (95% CI 0.46e0.82). This repre-
sented small changes (0.05) fromvalues reported in Table II which
included the entire control group (n ¼ 53).
Internal consistency
Two participants from the entire sample hadmissing items from
one of the pain scales. Only participants with complete data for
each pain measure at baseline were used to examine internalTable II
Control group scores, reliability statistics, and internal consistency statistics
Variable Mean (SD) control
baseline (n ¼ 53)
Mean (SD) control
2 weeks (n ¼ 53)
P4 23 (8) 23 (9)
WOMAC-Pain 10 (4) 10 (3)
ICOAP-total 49 (25) 46 (23)
ICOAP-constant 41 (33) 43 (31)
ICOAP-intermittent 55 (27) 49 (28)
WOMAC, Western Ontario and McMaster Universities Arthritis Index; ICOAP, Intermitten
correlation coefﬁcient (model 2,1); CI, conﬁdence intervals; SEM, standard error of the mconsistency of P4 (n ¼ 156), WOMAC-pain (n ¼ 155), and ICOAP
(n ¼ 155). All pain measures and subscales had Chronbach’s ɑ
values above 0.80 demonstrating acceptable internal consistency
(Table II). WOMAC-pain had the lowest Chronbach’s ɑ value and
ICOAP-constant had the highest.
Factorial structure
Missing item data for some participants in the entire sample at
baseline resulted in their exclusion from factorial structure ana-
lyses. In total, 154, 153 and 153 participants for the P4/WOMAC-
function, WOMAC-pain/WOMAC-function and ICOAP/WOMAC-
function respectively were analyzed. Principal component anal-
ysis of P4/WOMAC-function revealed three factors that accounted
for 66% of the variance. After rotation, WOMAC-function items
loaded on two factors and P4 items loaded on a separate, third
factor (Table III). In comparison, WOMAC-pain/WOMAC-function
items produced three factors which accounted for 66% of theICC2,1 (95% CI) SEM (95% CI) MDC90 Cronbach’s ɑ
0.72 (0.57, 0.83) 4.5 (3.7, 5.5) 10.3 0.91
0.79 (0.66, 0.87) 1.6 (1.4, 2.0) 3.8 0.87
0.73 (0.57, 0.83) 12.5 (10.5, 15.5) 29.0 0.93
0.77 (0.64, 0.86) 15.4 (12.9, 19.1) 35.8 0.97
0.61 (0.41, 0.75) 16.9 (14.2, 21.0) 39.3 0.93
t and Constant Osteoarthritis Pain measure; SD, standard deviation; ICC2,1, intraclass
easurement; MDC90, minimal detectable change at the 90% conﬁdence level.
Table V
ICOAP and WOMAC-function pattern matrix factor loading (n ¼ 153)
Items Factor 1 Factor 2 Factor 3 Factor 4
WOMAC-function
Difﬁculty socks off 0.83 0.00 0.09 0.06
Difﬁculty rising from sit 0.82 0.01 0.05 0.05
Difﬁculty socks on 0.78 0.01 0.10 0.06
Difﬁculty raise from bed 0.76 0.13 0.05 0.04
Difﬁculty in/out of bath 0.73 0.02 0.02 0.08
Difﬁculty on/off toilet 0.66 0.13 0.06 0.23
Difﬁculty in/out of car 0.56 0.00 0.06 0.31
Difﬁculty lying in bed 0.43 0.14 0.28 0.12
Difﬁculty stair ascent 0.33 0.19 0.09 0.33
Difﬁculty shopping 0.03 0.05 0.07 L0.86
Difﬁculty walking 0.09 0.10 0.05 L0.84
Difﬁculty standing 0.03 0.03 0.04 L0.79
Difﬁculty light duties 0.06 0.02 0.34 L0.57
Difﬁculty heavy duties 0.26 0.08 0.03 L0.55
Difﬁculty bending 0.17 0.03 0.09 L0.53
Difﬁculty sitting 0.18 0.04 0.30 L0.38
Difﬁculty stair descent 0.25 0.24 0.06 L0.30
ICOAP-intermittent
Intermittent-frustrated 0.06 0.88 0.06 0.01
Intermittent-pain frequency 0.08 0.87 0.24 0.14
Intermittent-quality of life 0.05 0.84 0.09 0.16
Intermittent-pain intense 0.12 0.80 0.03 0.05
Intermittent-worried 0.09 0.77 0.21 0.10
Intermittent-sleep 0.23 0.65 0.27 0.17
ICOAP-constant
Constant-worried 0.03 0.02 L0.96 0.01
Constant-frustrated 0.02 0.06 L0.93 0.04
Constant-quality of life 0.00 0.05 L0.93 0.00
Constant-pain intense 0.08 0.11 L0.86 0.12
Constant-sleep 0.05 0.04 L0.85 0.05
ICOAP, Intermittent and Constant Osteoarthritis Pain measure; WOMAC, Western
Ontario and McMaster Universities Arthritis Index. The highest factor loading for
each item on the different factors is presented in bolded text.
Table III
P4 and WOMAC-function pattern matrix factor loading (n ¼ 154)
Items Factor 1 Factor 2 Factor 3
WOMAC-function
Difﬁculty shopping 0.84 0.14 0.15
Difﬁculty walking 0.83 0.17 0.19
Difﬁculty standing 0.72 0.02 0.17
Difﬁculty stair descent 0.70 0.15 0.14
Difﬁculty heavy duties 0.64 0.16 0.08
Difﬁculty stair ascent 0.62 0.23 0.01
Difﬁculty bending 0.61 0.10 0.09
Difﬁculty light duties 0.55 0.23 0.14
Difﬁculty sitting 0.47 0.34 0.02
Difﬁculty socks off 0.05 0.87 0.05
Difﬁculty socks on 0.12 0.80 0.20
Difﬁculty raise from bed 0.09 0.75 0.01
Difﬁculty rising from sit 0.02 0.74 0.05
Difﬁculty in/out of bath 0.19 0.65 0.04
Difﬁculty on/off toilet 0.24 0.64 0.05
Difﬁculty lying in bed 0.25 0.55 0.11
Difﬁculty in/out of car 0.41 0.51 0.03
P4
Pain evening 0.04 0.10 L0.85
Pain afternoon 0.15 0.05 L0.80
Pain activities 0.23 0.03 L0.79
Pain morning 0.04 0.47 L0.55
WOMAC, Western Ontario and McMaster Universities Arthritis Index. The highest
factor loading for each item on the different factors is presented in bolded text.
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and there was no clear distinction between pain and physical
function subscales (Table IV). WOMAC-pain items (e.g., “Howmuch
pain do you have walking on a ﬂat surface”) loaded on the same
factors as their corresponding WOMAC-function items (e.g., “What
degree of difﬁculty do you have walking on a ﬂat surface”). ICOAP/
WOMAC-function principal component analysis revealed four fac-
tors accounting for 71% of the variance. WOMAC-function items
loaded on two factors while ICOAP-constant and ICOAP-
intermittent each loaded on separate factors (Table V). Assump-
tions for all principal component analyses were met including
adequate sample sizes (Kaiser-Meyer-Olkin Measure > 0.90)
and sufﬁcient correlations between items (Bartlett’s Test
signiﬁcance < 0.001).Table IV
WOMAC-pain and WOMAC-function pattern matrix factor loading (n ¼ 153).
WOMAC-pain items are in italics
Items Factor 1 Factor 2 Factor 3
Difﬁculty socks off 0.87 0.15 0.12
Difﬁculty socks on 0.85 0.13 0.09
Difﬁculty raise from bed 0.81 0.14 0.14
Difﬁculty rising from sit 0.72 0.08 0.10
Difﬁculty in/out of bath 0.67 0.03 0.11
Difﬁculty lying in bed 0.66 0.20 0.02
Difﬁculty on/off toilet 0.64 0.07 0.13
Difﬁculty in/out of car 0.56 0.24 0.12
Pain night 0.49 0.32 0.00
Difﬁculty walking 0.14 L0.85 0.19
Difﬁculty standing 0.06 L0.85 0.03
Pain standing 0.07 L0.78 0.04
Difﬁculty shopping 0.06 L0.74 0.22
Pain walking 0.02 L0.70 0.16
Difﬁculty light duties 0.33 L0.61 0.04
Difﬁculty sitting 0.43 L0.48 0.11
Pain sitting/lying 0.40 L0.45 0.06
Difﬁculty stair descent 0.05 0.05 0.88
Pain stairs 0.03 0.18 0.73
Difﬁculty stair ascent 0.19 0.03 0.72
Difﬁculty bending 0.07 0.22 0.59
Difﬁculty heavy duties 0.22 0.35 0.35
WOMAC, Western Ontario and McMaster Universities Arthritis Index. The highest
factor loading for each item on the different factors is presented in bolded text.Responsiveness
Some participants did not complete 2 week collection and only
participants from the intervention group with complete data were
used to examine responsiveness of P4 (n ¼ 93), WOMAC-pain
(n ¼ 92), and ICOAP (n ¼ 92). Descriptive statistics of baseline
and 2 week scores are provided in Table VI for the intervention
group. Themajority of painmeasures and subscales had SRM values
that represented moderate to large responsiveness with WOMAC-
pain having the highest SRM value (Table VI). Only ICOAP-
constant had small to moderate responsiveness.
Discussion
P4, a generic pain measure, had acceptable measurement
properties in patients with knee OA and can be used to evaluate
pain in this population. Responsiveness and test-retest reliability of
the P4 were comparable to OA disease speciﬁc pain measuresTable VI
Intervention group scores and SRM
Variable Mean (SD)
intervention
baseline
Mean (SD)
intervention
2 weeks
SRM (95% CI)
P4 (n ¼ 93) 20 (10) 16 (10) 0.56 (0.37, 0.78)
WOMAC-Pain (n ¼ 92) 8 (4) 7 (4) 0.65 (0.45, 0.87)
ICOAP-total (n ¼ 92) 43 (23) 33 (24) 0.58 (0.39, 0.80)
ICOAP-constant (n ¼ 92) 34 (31) 25 (28) 0.40 (0.21, 0.58)
ICOAP-intermittent (n ¼ 92) 51 (24) 40 (24) 0.51 (0.31, 0.73)
WOMAC, Western Ontario and McMaster Universities Arthritis Index; ICOAP,
Intermittent and Constant Osteoarthritis Pain measure; SD, standard deviation;
SRM, standardized response mean; CI, conﬁdence intervals.
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slightly higher reliability and responsiveness values (Tables II and
VI). P4 items loaded on factors that were separate from WOMAC-
physical function items demonstrating that P4 is capturing a
separate construct from physical function. P4 can be utilized to
measure pain in patients with knee OA considering its measure-
ment properties, single factorial structure, and it is quick to com-
plete and score. Furthermore, it has great utility in clinical settings
since it is a generic pain measure that has been validated in a
general musculoskeletal population thus limiting the need for
multiple disease speciﬁc measures13,14.
Only a few studies have provided a comprehensive comparison
of P4 and ICOAP measurement properties to other pain measures
and the current study provides perhaps the most complete com-
parison including reliability, internal consistency, factorial struc-
ture, and responsiveness6,7,27. A previous study found similar P4
internal consistency (Chronbach’s ɑ ¼ 0.93) in patients with knee
OA7. Patients with any musculoskeletal condition had comparable,
but slightly higher test-retest reliability (ICC2,1 ¼ 0.78) and lower
MDC90 (9.1 points) for the P414. Likewise, current test-retest reli-
ability (Table II) was lower compared to studies evaluating patients
with knee OA for ICOAP (ICC ¼ 0.85) but within the range of pre-
vious values for WOMAC-pain (ICC ¼ 0.65e0.90)6,9,11,29. The pre-
vious ICOAP study had 7% of participants awaiting joint
arthroplasty while 49% received joint arthroplasty in the current
sample6. This greater proportion of participants with severe OA
could result in lower test-retest reliability due to these measures
being less stable in patients with severe compared to mild to
moderate OA.
P4, WOMAC-pain and ICOAP all demonstrated acceptable in-
ternal consistency (Chronbach’s ɑ > 0.80) (Table II). However, there
were drastic differences in the factorial structure. Similar to pre-
vious work, P4 items loaded on a separate factor than WOMAC-
function items when combined in a principal component anal-
ysis7. Thus, factorial structure of P4 is separate from WOMAC-
function demonstrating that these measures capture different
constructs: pain and physical function. For the P4/WOMAC-
function analysis (Table III), the two factors representing
WOMAC-function items appeared to capture transitions between
positions (e.g., “Rising from sitting”) and non-transition activities
(e.g., “Walking on a ﬂat surface”); however, not all WOMAC-
function items ﬁt these proposed constructs (e.g., “Lying in bed”).
WOMAC-pain items loaded on the same factors as WOMAC-
function items supporting previous work7,10. WOMAC-pain items
(e.g., “How much pain do you have walking on a ﬂat surface”) load
on the same factor as their corresponding WOMAC-function item
(e.g., “What degree of difﬁculty do you have walking on a ﬂat sur-
face”). Thus, WOMAC-pain is capturing physical function status
alongwith pain status. ICOAP items loaded on separate factors from
WOMAC-function. Furthermore, ICOAP-constant items and ICOAP-
intermittent items each loaded on separate factors demonstrating
that these subscales represent separate pain domains (Table V).
Interestingly, a previous study failed to demonstrate that ICOAP-
constant and intermittent subscales demonstrated separate pain
domains6. The conﬂicting ﬁnding could be explained by the pre-
vious study examined patients with hip and knee OA and only a
small proportion were on a waiting list for joint arthroplasty (7%)
representing a less severe sample6. ICOAP-intermittent and ICOAP-
constant did demonstrate the ability to measure separate pain
domains in another study using Rasch analysis once some items
were deleted30. Additional reﬁnement of ICOAP and testing of its
factorial structures are required to determine if it can capture
separate pain domains (i.e., constant and intermittent pain).
The ICOAP-constant ﬂoor effect was higher (33%) than previous
reports (5% and 6%)30,31. This was surprising given that participantswere consulting with an orthopedic surgeon for a potential knee
arthroplasty. Distribution of mild, moderate, and severe radio-
graphic knee OAwas similar between participants with no constant
pain (17, 29, 54% respectively) and participants with some constant
pain (11, 30, 59% respectively) and thus disease severity unlikely
accounted for the ICOAP-constant ﬂoor effect. We subjectively
noticed participants required clariﬁcation of what was meant by
“constant pain” although it appears clearly described on ICOAP
instructions (“pain you have all the time”). Participants requiring
clariﬁcation were told that constant pain means “pain all the time”
and perhaps our clariﬁcation inﬂuenced their interpretation of the
scale. In the development of ICOAP, patients with OA identiﬁed the
importance of distinguishing between constant and intermittent
pain and this is one of the advantages of ICOAP6. Thus, even if pa-
tients do not have constant pain, their pain status can still be
captured utilizing ICOAP-intermittent subscale and total score. Only
1% (n ¼ 2) of participants had a ﬂoor effect for the ICOAP-total.
Furthermore, assessing which patients do not have constant pain
also provides useful clinical information regarding symptom
severity. Removal of participants with ﬂoor effects at baseline
resulted in only small changes in ICC2,1 values for ICOAP-constant
and ICOAP-total but responsiveness increased (SRM ¼ 0.67,
n ¼ 62). Also, we examined if the ﬂoor effect could inﬂuence ICOAP
factorial structure. There was no change in the interpretation of the
factorial structure of ICOAP/WOMAC-function once participants
with a baseline ICOAP-constant of 0 were removed (Supplemental
Table 1).
SEM values (Table II) can be utilized to estimate measurement
error in individual patients. For instance, P4 measurement error at
95% conﬁdence level is 9 (measurement error ¼ SEM  z-value at a
speciﬁed level of conﬁdence; e.g., 1.96 at 95% conﬁdence level).
Thus, you would be 95% conﬁdent that the true score for a patient
with a measured P4 score of 20 is between 11 and 29. Furthermore,
MDC90 can be used to evaluate individual patient change in
response to interventions. A patient with a P4 score of 20 would
need to decrease their score by 10 (MDC90 ¼ 10.3) in order to be
considered a true change. Thus, SEM andMDC90 values can be used
clinically to assess individual change in patients with knee OA.
SRM as a measure of responsiveness does present with limita-
tions. The denominator of SRM is the standard deviation of change
scores. SRM could be inﬂated if all participants changed by similar
amounts32. This was unlikely the case for the current study. For
example, P4 scores in the intervention group showed improve-
ment, worsening, or no change in 68, 27, and 5% of participants
respectively. Thus, sufﬁcient variability was present in change
scores as to not inﬂate SRM. An additional limitation includes this
was a secondary analysis and sample size calculations for current
analyses were not performed a priori. Stability of the test-retest
reliability sample or improvements in the responsiveness sample
were not conﬁrmed with a participant reported anchor item (e.g.,
global rating of change). Potential changes in pain status in the test-
retest reliability sample could have decreased ICC2,1 values. Like-
wise, a lack of improvement in response to the intervention could
have decreased responsiveness values. Regardless, acceptable test-
retest reliability and responsiveness were found for the majority of
pain measures. Finally, participants were consulting with an or-
thopedic surgeon for possible knee arthroplasty and the majority of
participants had severe radiological OA. The generalizability of
these results to less severe populations should be conﬁrmed.
In summary, P4 is a generic pain measure that can be utilized to
measure pain in patients with knee OA. It had comparable reli-
ability, internal consistency, and responsiveness to OA disease
speciﬁc pain measures. When choosing a pain measure, in-
vestigators should consider the intended purpose of the study and
the outcomes (e.g., pain intensity) that are expected to improve as a
S.M. Robbins et al. / Osteoarthritis and Cartilage 22 (2014) 805e812 811result of an intervention. For instance, if the main objective of a
study is to capture pain intensity, then P4 is an appropriate mea-
sure. If investigators are interested in the pain experience during
physical activities, thenWOMAC-pain might be a more appropriate
choice. However, the factorial structure of the WOMAC does not
distinguish between pain and physical function items. Thus, it is
unclear if it is measuring pain or difﬁculty performing physical
activities. Additional work is required to compare P4 to other pain
measures in patients with mild and moderate knee OA severity.
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